Trial Profile

A global Phase 3 trial of 4D 150 in Diabetic macular oedema.

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 30 Jan 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 4D-150 (Primary)
Indications Diabetic macular oedema
Focus Therapeutic Use

Most Recent Events

20 Jan 2026 New trial record
06 Jan 2026 According to 4D Molecular Therapeutics media release, 4D-150 DME global Phase 3 trial initiation expected Q3 2026.
06 Jan 2026 According to 4D Molecular Therapeutics media release, Phase 3 trial design expected mid-2026 and Global Phase 3 trial initiation expected in H2 2026.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com